Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening

Research Paper
  • 40 Downloads

Abstract

Volatile organic compounds (VOCs) in breath can be used as biomarkers to identify early stages of lung cancer. Herein, we report a disposable colorimetric array that has been constructed from diverse chemo-responsive colorants. Distinguishable difference maps were plotted within 4 min for specifically targeted VOCs. Through the consideration of various chemical interactions with VOCs, the arrays successfully discriminate between 20 different volatile organic compounds in breath that are related to lung cancer. VOCs were identified either with the visualized difference maps or through pattern recognition with an accuracy of at least 90%. No uncertainties or errors were observed in the hierarchical cluster analysis (HCA). Finally, good reproducibility and stability of the array was achieved against changes in humidity. Generally, this work provides fundamental support for construction of simple and rapid VOC sensors. More importantly, this approach provides a hypothesis-free array method for breath testing via VOC profiling. Therefore, this small, rapid, non-invasive, inexpensive, and visualized sensor array is a powerful and promising tool for early screening of lung cancer.

Graphical abstract

A disposable colorimetric array has been developed with broadly chemo-responsive dyes to incorporate various chemical interactions, through which the arrays successfully discriminate 20 VOCs that are related to lung cancer via difference maps alone or chemometrics within 4 min. The hydrophobic porous matrix provides good stability against changes in humidity.

Keywords

VOCs Lung cancer Classification Chemo-responsive Colorimetric array Pattern recognition 

Notes

Acknowledgements

This work was supported by the National Natural Science Foundation of China (NSFC) (No. 81772290), Chongqing Graduate Student Research Innovation Project (No. CYB17037), the Workstation in Sichuan Province GY2015-01, and the sharing fund of Chongqing University’s large equipment for financial support.

Compliance with ethical standards

Conflict of interest

The authors declare that no conflict exists and the study has not involved human participants or animals.

Supplementary material

216_2018_948_MOESM1_ESM.pdf (126 kb)
ESM 1 (PDF 126 kb)

References

  1. 1.
    Jemal A, Siegel S, Xu JQ, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.  https://doi.org/10.1002/caac.20073.CrossRefGoogle Scholar
  2. 2.
    Stewart BW, Wild CP, World Health Organization (2014) World cancer report 2014. International Agency for Research on Cancer 16.Google Scholar
  3. 3.
    Cutler DM. Are we finally winning the war on cancer? J Econ Perspect. 2008;22:3–26.CrossRefGoogle Scholar
  4. 4.
    Khan Y, Ostfeld AE, Lochner CM, Pierre A, Arias AC. Monitoring of vital signs with flexible and wearable medical devices. Adv Mater. 2016;28(22):4373–95.  https://doi.org/10.1002/adma.201504366.CrossRefGoogle Scholar
  5. 5.
    Shirasu M, Touhara K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem. 2011;150(3):257–66.  https://doi.org/10.1093/jb/mvr090.CrossRefGoogle Scholar
  6. 6.
    Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality, the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA. 2011;306(17):1865–73.  https://doi.org/10.1001/jama.2011.1591.CrossRefGoogle Scholar
  7. 7.
    The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.CrossRefGoogle Scholar
  8. 8.
    Roberts HC, Patsios D, Paul NS, McGregor M, Weisbrod G, Chung T, et al. Lung cancer screening with low-dose computed tomography: Canadian experience. Can Assoc Radiol J. 2007;58(4):225–35.Google Scholar
  9. 9.
    Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev Mol Diagn. 2011;11(2):207–17.  https://doi.org/10.1586/erm.10.112.CrossRefGoogle Scholar
  10. 10.
    Gao W, Emaminejad S, Nyein HYY, Challa S, Chen K, Peck A, et al. Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis. Nature. 2016;529(7587):509–14.  https://doi.org/10.1038/nature16521.CrossRefGoogle Scholar
  11. 11.
    Konvalina G, Haick H. Sensors for breath testing: from nanomaterials to comprehensive disease detection. Acc Chem Res. 2014;47:66–76.CrossRefGoogle Scholar
  12. 12.
    Kim SJ, Choi SJ, Jang JS, Cho HJ, Kim ID. Innovative nanosensor for disease diagnosis. Acc Chem Res. 2017;50(7):1587–96.  https://doi.org/10.1021/acs.accounts.7b00047.CrossRefGoogle Scholar
  13. 13.
    Broza YY, Haick H. Nanomaterial-based sensors for detection of disease by volatile organic compounds. Nanomedicine. 2013;8(5):785–806.  https://doi.org/10.2217/nnm.13.64.CrossRefGoogle Scholar
  14. 14.
    Anthony PFT, Magan N. Electronic noses and disease diagnostics. Nat Rev Microbiol. 2004;2:161–6.CrossRefGoogle Scholar
  15. 15.
    O'Neill HJ, Gordon SM, O'Neill MH, Gibbons RD, Szidon JP. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem. 1988;34:1613–8.Google Scholar
  16. 16.
    Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999;353(9168):1930–3.  https://doi.org/10.1016/S0140-6736(98)07552-7.CrossRefGoogle Scholar
  17. 17.
    Smith D, Wang TS, Sulé-Suso J, Španěl P, Haj AE. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom. 2003;17(8):845–50.  https://doi.org/10.1002/rcm.984.CrossRefGoogle Scholar
  18. 18.
    Kamat PC, Roller CB, Namjou K, Jeffers JD, Faramarzalian A, Salas R, et al. Measurement of acetaldehyde in exhaled breath using a laser absorption spectrometer. Appl Opt. 2007;46:3969–75.CrossRefGoogle Scholar
  19. 19.
    Giubileo G. Medical diagnostics by laser-based analysis of exhaled breath. Proc SPIE. 2002;4762:318–25.CrossRefGoogle Scholar
  20. 20.
    Yu H, Xu L, Cao MF, Chen X, Wang P, Jiao JW, et al. Detection of volatile organic compounds in breath as markers of lung cancer using a novel electronic nose. Proc IEEE Sens. 2003;2:1333–7.Google Scholar
  21. 21.
    Natale CD, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, Roscioni C, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron. 2003;18(10):1209–18.  https://doi.org/10.1016/s0956-5663(03)00086-1.CrossRefGoogle Scholar
  22. 22.
    Righettoni M, Ragnoni A, Güntner AT, Loccioni C, Pratsinis SE, Risby TH. Monitoring breath markers under controlled conditions. J Breath Res. 2015;9(4):047101.  https://doi.org/10.1088/1752-7155/9/4/047101.CrossRefGoogle Scholar
  23. 23.
    Haick H, Broza YY, Mochalski P, Ruzsanyi V, Amann A. Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev. 2014;43(5):1423–49.  https://doi.org/10.1039/c3cs60329f.CrossRefGoogle Scholar
  24. 24.
    Feller JF, Grohens Y. Evolution of electrical properties of some conductive polymer composite textiles with organic solvent vapours diffusion. Sensors Actuators B Chem. 2003;97(2-3):231–42.  https://doi.org/10.1016/j.snb.2003.08.021.CrossRefGoogle Scholar
  25. 25.
    Gallazzi MC, Tassoni L, Bertarelli C, Pioggia G, Di Francesco F, Montoneri E. Poly(alkoxy-bithiophenes) sensors for organic vapours. Sensors Actuators B Chem. 2003;88(2):178–89.  https://doi.org/10.1016/s0925-4005(02)00323-4.CrossRefGoogle Scholar
  26. 26.
    Hsieh MD, Zellers ET. Limits of recognition for simple vapor mixtures determined with a microsensor array. Anal Chem. 2004;76(7):1885–95.  https://doi.org/10.1021/ac035294w.CrossRefGoogle Scholar
  27. 27.
    Jin CG, Zeellers ET. Limits of recognition for binary and ternary vapor mixtures determined with multitransducer arrays. Anal Chem. 2008;80(19):7283–93.  https://doi.org/10.1021/ac8008912.CrossRefGoogle Scholar
  28. 28.
    Zampolli S, Elmi I, Ahmed F, Passini M, Cardinali GC, Nicoletti S, et al. An electronic nose based on solid state sensor arrays for low-cost indoor air quality monitoring applications. Sensors Actuators B Chem. 2004;101(1-2):39–46.  https://doi.org/10.1016/j.sub.2004.02.024.CrossRefGoogle Scholar
  29. 29.
    Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol. 2009;4(10):669–73.  https://doi.org/10.1038/nnano.2009.235.CrossRefGoogle Scholar
  30. 30.
    Buszewski B, Ligor T, Jezierski T, Wenda-Piesik A, Walczak M, Rudnicka J. Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines. Anal Bioanal Chem. 2012;404(1):141–6.  https://doi.org/10.1007/s00216-012-6102-8.CrossRefGoogle Scholar
  31. 31.
    Mazzone PJ, Wang XF, Xu YM, Mekhail T, Beukemann MC, Na J, et al. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol. 2012;7:137–42.CrossRefGoogle Scholar
  32. 32.
    Zou YC, Zhang X, Chen X, Hu YJ, Ying KJ, Wang P. Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease. Cancer Biomark. 2014;14(5):371–9.  https://doi.org/10.3233/CBM-140418.CrossRefGoogle Scholar
  33. 33.
    Filipiak W, Filipiak A, Sponring A, Schmid T, Zelger B, Ager C, et al. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. J Breath Res. 2014;8(2):027111.  https://doi.org/10.1088/1752-7155/8/2/027111.CrossRefGoogle Scholar
  34. 34.
    Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, Tutino M, et al. Exhaled volatile organic compounds identify patients with colorectal cancer. Brit J Surg. 2013;100(1):144–50.  https://doi.org/10.1002/bjs.8942.CrossRefGoogle Scholar
  35. 35.
    Dragonieri S, van der Schee MP, Massaro T, Schiavulli N, Brinkman P, Pinca A, et al. An electronic nose distinguishes exhaled breath of patients with malignant pleural mesothelioma from controls. Lung Cancer. 2012;75(3):326–31.  https://doi.org/10.1016/j.lungcan.2011.08.009.CrossRefGoogle Scholar
  36. 36.
    McWilliams A, Beigi P, Srinidhi A, Lam S, MacAulay CE. Sex and smoking status effects on the early detection of early lung cancer in high-risk smokers using an electronic nose. IEEE Trans Biomed Eng. 2015;62(8):2044–54.  https://doi.org/10.1109/tbme.2015.2409092.CrossRefGoogle Scholar
  37. 37.
    Broza YY, Kremer R, Tisch U, Gevorkyan A, Shiban A, Best LA, et al. A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine. 2013;9(1):15–21.  https://doi.org/10.1016/j.nano.2012.07.009.CrossRefGoogle Scholar
  38. 38.
    Hakim M, Billan S, Tisch U, Peng G, Dvrokind I, Marom O, et al. Diagnosis of head-and-neck cancer from exhaled breath. Br J Cancer. 2011;104(10):1649–55.  https://doi.org/10.1038/bjc.2011.128.CrossRefGoogle Scholar
  39. 39.
    Shehada N, Brönstrup G, Funka K, Christiansen S, Leja M, Haick H. Ultrasensitive silicon nanowire for real-world gas sensing: noninvasive diagnosis of cancer from breath volatolome. Nano Lett. 2015;15(2):1288–95.  https://doi.org/10.1021/nl504482t.CrossRefGoogle Scholar
  40. 40.
    Amal H, Shi DY, Ionescu R, Zhang W, Hua QL, Pan YY, et al. Assessment of ovarian cancer conditions from exhaled breath. Int J Cancer. 2015;136(6):614–22.  https://doi.org/10.1002/ijc.29166.CrossRefGoogle Scholar
  41. 41.
    Gruber M, Tisch U, Jeries R, Amal H, Hakim M, Ronen O, et al. Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study. Br J Cancer. 2014;111(4):790–8.  https://doi.org/10.1038/bjc.2014.361.CrossRefGoogle Scholar
  42. 42.
    Phillips M, Beatty JD, Cataneo RN, Huston J, Kaplan PD, Lalisang RI, et al. Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms. PLoS One. 2014;9(3):90226.  https://doi.org/10.1371/journal.pone.0090226.t001.CrossRefGoogle Scholar
  43. 43.
    Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P, Wai J. Volatile biomarkers in the breath of women with breast cancer. J Breath Res. 2010;4(2):026003.  https://doi.org/10.1088/1752-7155/4/2/026003.CrossRefGoogle Scholar
  44. 44.
    Guo L, Wang CS, Chi CJ, Wang XY, Liu SS, Zhao W, et al. Exhaled breath volatile biomarker analysis for thyroid cancer. Transl Res. 2015;166(2):188–95.  https://doi.org/10.1016/j.trsl.2015.01.005.CrossRefGoogle Scholar
  45. 45.
    Wang CS, Ke CF, Wang XY, Chi CJ, Guo L, Luo SQ, et al. Noninvasive detection of colorectal cancer by analysis of exhaled breath. Anal Bioanal Chem. 2014;406(19):4757–63.  https://doi.org/10.1007/s00216-014-7865-x.CrossRefGoogle Scholar
  46. 46.
    Poli D, Goldoni M, Corradi M, Acampa O, Carbognani P, Internullo E, et al. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J Chromatogr B. 2010;878(27):2643–51.  https://doi.org/10.1016/j.jchromb.2010.01.022.CrossRefGoogle Scholar
  47. 47.
    Janzen MC, Ponder JB, Bailey DP, Ingison CK, Suslick KS. Colorimetric sensor arrays for volatile organic compounds. Anal Chem. 2006;78(11):3591–600.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of BioengineeringChongqing UniversityChongqingChina

Personalised recommendations